Peptides: activating autophagy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 3
Results: 23
1
2
Targeting pathological B cell receptor signalling in lymphoid malignancies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 229, doi. 10.1038/nrd3937
- By:
- Publication type:
- Article
3
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 180, doi. 10.1038/nrd3973
- By:
- Publication type:
- Article
4
Neurodegenerative disease: Toll-like receptor 4 agonist shows benefit in AD.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 190, doi. 10.1038/nrd3965
- By:
- Publication type:
- Article
5
G protein-coupled receptors: finding common threads.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Ocular disorders: A new target in age-related macular degeneration.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 190, doi. 10.1038/nrd3968
- By:
- Publication type:
- Article
7
The role of tumour-stromal interactions in modifying drug response: challenges and opportunities.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 217, doi. 10.1038/nrd3870
- By:
- Publication type:
- Article
8
Antibiotics: Boosting antibiotic activity via ROS.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 190, doi. 10.1038/nrd3967
- By:
- Publication type:
- Article
9
Stem cell therapy market.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 185, doi. 10.1038/nrd3953
- By:
- Publication type:
- Article
10
Cancer: double-pronged approach to combat mutant KRAS.
- Published in:
- 2013
- By:
- Publication type:
- journal article
11
Tuberculosis success.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 175, doi. 10.1038/nrd3957
- By:
- Publication type:
- Article
12
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 177, doi. 10.1038/nrd3972
- Publication type:
- Article
13
Trial watch: Pioneering RNAi therapy shows antitumour activity in humans.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 178, doi. 10.1038/nrd3962
- By:
- Publication type:
- Article
14
Cancer: A target for drug resistance.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 190, doi. 10.1038/nrd3966
- By:
- Publication type:
- Article
15
Regenerative disorders: notching up hearing.
- Published in:
- 2013
- By:
- Publication type:
- journal article
16
Epigenetic drugs: new modulators of readers and erasers.
- Published in:
- 2013
- By:
- Publication type:
- journal article
17
The placebo response in medicine: minimize, maximize or personalize?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 191, doi. 10.1038/nrd3923
- By:
- Publication type:
- Article
18
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 169, doi. 10.1038/nrd3971
- Publication type:
- Article
19
Signalling bias in new drug discovery: detection, quantification and therapeutic impact.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 205, doi. 10.1038/nrd3954
- By:
- Publication type:
- Article
20
Nanomedicine: is the wave cresting?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 171, doi. 10.1038/nrd3958
- By:
- Publication type:
- Article
21
Regulatory watch: Antisense approval provides boost to the field.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 179, doi. 10.1038/nrd3963
- By:
- Publication type:
- Article
22
Chris Austin.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 182, doi. 10.1038/nrd3960
- Publication type:
- Article
23
European Lead Factory opens for business.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 173, doi. 10.1038/nrd3956
- By:
- Publication type:
- Article